Previous studies have indicated that G6PD overexpression was associated with a poor prognosis in certain types of cancer, including AML, hepatocellular carcinoma, invasive breast carcinoma, and mesothelioma (36). This evidence concerns the gene G6PD and invasive breast carcinoma.